2023 European Meeting of ISMPP, London UK
Join our healthy debate at the 2023 European Meeting of ISMPP and explore new frontiers with Oxford PharmaGenesis.
Featured
24 January 2024
ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
All
- All
- News
- Articles
- Events
Keeping evidence current: living systematic reviews
To ensure that patients receive optimal healthcare, clinicians rely on the best available evidence, which is often synthesized in a systematic literature review (SLR) or meta-analysis. The problem is that research never stands still, so new findings are constantly being published. This means that unless an SLR is continually updated, new findings may remain buried…
APPA-MAPS 22: highlights of the inaugural ANZ Medical Affairs summit
Space medicine, digital health and the patient voice were just some of the topics explored at the inaugural 2022 Australian Pharmaceutical Professionals Association (APPA) and Medical Affairs Professional Society (MAPS) joint Medical Affairs summit for the Australia and New Zealand (ANZ) region, held on 17 and 18 November in Sydney, Australia.
CISCRP Patient Diversity Campaign sponsorship: part of our commitment to EDI
As part of our commitment to promoting equality, diversity and inclusivity (EDI) in the workplace and across the work that we do, Oxford PharmaGenesis is proud to sponsor the latest CISCRP educational media campaign which promotes greater patient diversity in clinical trials.
Joint article by Oxford PharmaGenesis, Digital Science and Pfizer reaches most reads in Cancer Informatics over the last 6 months
Published in late March in Cancer Informatics, our paper (Wager et al., 2022) has accumulated 11 000 views in the last 6 months. This is twice as many as the second most read article in the journal, five times that of the third most read, and 43 times the number of views that the average article…
ISMPP West 2022
Oxford PharmaGenesis is proud to sponsor ISMPP West 2022. On this page you can find information about our award-winning work and white papers, leaflets and more.
